CV Sciences Inc (CVSI)

[MartyTamreau]

I agree. While I was expecting more revenue related to the increased number of retail stores, the reduction in expenses is tremendous. In addition, I am reading into this that they have no need for new inventory in 2016; i.e., their inventory is already paid for last year, so the cost of goods will be ridiculously low this entire year. Think serious profit margin. It's clear that leadership is being efficient with finances. It's a lean organization of 37 people (Yahoo finance). The pharma side is the future and a compelling one; but until then, they will have a thriving commercial business. Unlike pharma development companies, which bleed money until a product is developed, CANV will have an ongoing, increasingly profitable business until then. Progressing in pharma development will be costly and they will need significantly more revenue and partnership. But overall, a very good report. And when you compare us to other similar companies, we look especially strong. Staying long for a long time.